1.Photoprotective Effect of Various Sunscreens Against Ultraviolet B - induced Chronic Skin Damage.
Hyun Joo CHOI ; Seung Kyung HANN ; Yoon Kee PARK
Korean Journal of Dermatology 1995;33(1):8-18
BACKGROUND: Chronic exposure to ultraviolet radiation(UVE) nduces photoaging characterized by dry, deeply wrinkled, inelastic, leathery, and irregulaity pigmented skin. UVR also induces solar keratosis and carcinoma, and is a contributing factor in melanoma. Sunscreens are used to prevent solar damage to skin and, if used on a daily lass should significantly reduce the incidence of the chronie photodamaging events. OBJECTIVE: We tried to evaulate the photoaging effects of UVR in the skin and the photoprotective effect of sunscreens. METHOD: We examined the gross and microscopic changes skin of albino hairless Skh : HR-1 mice exposed chronically to ultraviolet B(UVB) and suncreen-treated mice. RESULTS: The skin of the UVB-irradiated mouse shows chear, cteristic signs of photoaging, such as deep wrinkles across the back, and thickened and a hery skin. Histologically, the photoaged skin shows increased epidermal thickness, numeross fibroblasts and inflammatory cell infiltration in the upper dermis, and many enlarged keratering cysts in the lower dermis. By the 20th week, seven of the total of 9 mice(78%) in UVB irradiated mice developed at least one tumor. Histologically, the tumor is a papilloma, but the he are many dyskeratotic cells and loss of polarity in epidermis. Octyl methoxycinnamate or TiO ZnO Talc-treated mic show a significantly decreased wrinkling score, mimmal epidermal hyperplasia, slightly increased dermal cellularity, and lack of proliferation of cysts. The octyl dimethyl PABA-treatd mice shows significantly increased wrinkling score and marked inflammatory infiltration dermis. By the 20th week, only one mouse had developed a tumor in the octyl methoxy irmamate-treated group and no evidence of tumor was seen in the TiO ZnO Talc-treated group. In the octyl dimethyl PABA-treated group, five of 7 mice(71%) developed at least one tumor. CONCLUSION: The skin which is chronically exposed to UVB is subject to photoaging and photocarcinogenesis and regular use of an adequate sunscreen would prevent these photodamaging effects of UVB.
Animals
;
Dermis
;
Epidermis
;
Fibroblasts
;
Hyperplasia
;
Incidence
;
Keratosis
;
Melanoma
;
Mice
;
Mice, Hairless
;
Papilloma
;
Skin*
;
Sunscreening Agents*
2.Distribution of catecholamine in nasal mucosa in perennial allergicrhinitis.
Jeung Gweon LEE ; Joo Heon YOON ; Seung Chul LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1992;35(2):302-308
No abstract available.
Nasal Mucosa*
3.The clinical findings of the knee joint tuberoulosis and treatment with synovectomy for preservation of the knee joint motion.
jae In AHN ; Yeo Seung YOON ; Joo Hong KIM
The Journal of the Korean Orthopaedic Association 1993;28(6):2215-2220
No abstract available.
Knee Joint*
;
Knee*
4.Respiratory Distress Syndrome of the New born Infants and Complications of Pregnancy.
Yoon Joo CHOI ; Eun Ai LEE ; Seung Joo LEE ; Keun LEE
Journal of the Korean Pediatric Society 1983;26(2):118-123
No abstract available.
Humans
;
Infant*
;
Pregnancy*
5.Generalized Cutaneous Pseudolymphoma Associated with Phenytoin Therapy.
Hyun Joo CHOI ; Ju Ho YOON ; Seung Kyung HANN ; Yoon Kee PARK
Korean Journal of Dermatology 1995;33(1):145-149
The term pseudolymphoma is not specific, and a variety of infl; m atory reactions may simulate clinically and histopat,hologically a cutaneous malignant lymphomas udolymphoma induced by drug therapies, especially anticonvulsants, have been reportecl. These pseidayrnphornas most commonly appear as single lesions. Characteristically, few localized lesions disappear after discontinuing therapy with the offending drug. Multiple and generalized tumors are very rate. We report a case of generalized cutaneous pseudolymphoma assocated with phenytoin therapy in a 52-year old male patient.
Anticonvulsants
;
Drug Therapy
;
Humans
;
Lymphoma
;
Male
;
Middle Aged
;
Phenytoin*
;
Pseudolymphoma*
7.The Non-Squamous Cell Cancers of the Larynx.
Joon Bum JOO ; Seung Joo YOO ; Soon Yuhl NAM ; Sang Yoon KIM
Korean Journal of Otolaryngology - Head and Neck Surgery 2001;44(11):1199-1205
BACKGROUND AND OBJECTIVES: The majority of laryngeal tumors are known to be SCC (squamous cell carcinoma). Non-SCC (non-squamous cell cancers) of the larynx represent a diverse spectrum of diseases with different prognosis and ratio-nales of management from SCC. Therapeutic options to these tumors depend on their histopathological characteristics and clinical behaviors. The purpose of this study was to assess the unique aspects of the non-SCC and to draw diagnosis and provide management options and prognostic variables. MATERIALS AND METHOD: Eleven non-SCC of the larynx from the 212 patients who were diagnosed with larynx cancer during their 3-year visits from 1997 to 2000 were reviewed retrospectively. RESULTS: The incidence of non-SCC was 5.2%. Pathology of non-SCC revealed 3 cases of malignant lymphoma, 2 cases of verrucous cell carcinoma and neuroendocrine carcinoma one case each of basaloid squamous cell carninoma, salivary duct carcinoma, adenocarcinoma, and spindle cell carcinoma. The most common site of origin was supraglottis (6 case, 56.5%), followed by glottis (4 cases, 36.4%) and subglottis (2 cases, 17.2%). Non-Hodgkin's lymphomas and basaloid squamous cell carninoma were treated by chemotherapy. The remaining cases were treated with surgery followed by postoperative radio-therapy or postoperative chemotherapy. The mean follow-up period was 26.8 months (12-43 months). CONCLUSION: Non-SCC accounts for approximately 5.2% of all malignancies of the larynx. Tissue biopsy is the most important diagnostic tool for the non-SCC of the larynx and the tissue sample must be obtained from the deep portion of the submucosal layer. Except for malignant lymphomas, the combined therapy that includes surgery would be the best method of treatment for non-SCC.
Adenocarcinoma
;
Biopsy
;
Carcinoma, Neuroendocrine
;
Diagnosis
;
Drug Therapy
;
Follow-Up Studies
;
Glottis
;
Humans
;
Incidence
;
Laryngeal Neoplasms
;
Larynx*
;
Lymphoma
;
Lymphoma, Non-Hodgkin
;
Pathology
;
Prognosis
;
Retrospective Studies
;
Salivary Ducts
8.Clinical Study of 174 Patient with Generalized Vitiligo.
Seung Kyung HANN ; Yoon Kee PARK ; Kyu Chun WHANG ; Hyung Joo KIM
Korean Journal of Dermatology 1986;24(6):798-805
This is an analysis of 174 patients classified as generalized vitiligo by Ortonnes' classification during the period from May till December in 1985. The retults are summarized as follows. There were 89 females(51.l%) and 85 males(48, 9%). 2. The mean age of onset was 24.2 years(male: 23.4, female: 24. 8). 3. The mean age at the first visit was 33 years(male: 32. 2, female: 34, 8) 4. The mean duration of t.he disease was 10. 8 years (male: 10. 3, female: 11. 3). 5. The mean interval between onset and visiting was 9 years(male: 8. 8, female: 10). 6. Mode of onset was unicentric in 90, 2% and multicentric in 9. 8% 7.The most common site of initial involvement was abdomen(15. 0%). 8. The most common precipitating factor was trauma(11%). 9.The most common previous treatment was sunlight irradiation after application of topical oxoralene(33.3%). 10. The most common degree of depigmented lesion was 5~10%.(39.7%). 1l. Family history was present in 12% and thyroid disease was associated in only one case.
Age of Onset
;
Classification
;
Female
;
Humans
;
Precipitating Factors
;
Sunlight
;
Thyroid Diseases
;
Vitiligo*
9.Photoallergic Dermatitis due to 8-Methoxypsoralen.
Hyun Joo CHOI ; Seung Kyung HANN ; Yoon Kee PARK ; Sang Hyun CHIN
Annals of Dermatology 1998;10(3):199-202
One adverse effect of PUVA therapy is the development of severe dermatitis. Only a few cases of photoallergy to psoralens during PUVA therapy have been reported. We describe herein a patient with photoallergic dermatitis induced by PUVA with 8-methoxypsoralen(8-MOP). A 38-year old woman with generalized vitiligo had acute pruritic exanthematous maculopapular lesions in the treated areas after PUVA therapy with 8-MOP. A patch test and photopatch test were performed with 8-MOP, 5-MOP, and 4,5,8-trimethylpsoralen(TMP). The patch test carried out with these psoralen derivatives were all negative, but the photopatch test showed a positive reaction to 8-MOP. The patient consequently had PUVA therapy with 5-MOP and she had no further experience of a photoallergic reaction.
Dermatitis
;
Dermatitis, Photoallergic*
;
Female
;
Ficusin
;
Furocoumarins
;
Humans
;
Methoxsalen*
;
Patch Tests
;
PUVA Therapy
;
Vitiligo
10.Molecular Targets of Dietary Polyphenols with Anti-inflammatory Properties.
Joo Heon YOON ; Seung Joon BAEK
Yonsei Medical Journal 2005;46(5):585-596
There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity. Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have long been used to combat inflammation. Recently, cyclooxygenase (COX) inhibitors have been developed and recommended for treatment of rheumatoid arthritis (RA) and osteoarthritis (OA). However, two COX inhibitors have been withdrawn from the market due to unexpected side effects. Because conventional therapeutic and surgical approaches have not been able to fully control the incidence and outcome of many inflammatory diseases, there is an urgent need to find safer compounds and to develop mechanism-based approaches for the management of these diseases. Polyphenols are found in many dietary plant products, including fruits, vegetables, beverages, herbs, and spices. Several of these compounds have been found to inhibit the inflammation process as well as tumorigenesis in experimental animals; they can also exhibit potent biological properties. In addition, epidemiological studies have indicated that populations who consume foods rich in specific polyphenols have lower incidences of inflammatory disease. This paper provides an overview of the research approaches that can be used to unravel the biology and health effects of polyphenols. Polyphenols have diverse biological effects, however, this review will focus on some of the pivotal molecular targets that directly affect the inflammation process.
Phospholipases A/antagonists & inhibitors
;
Phenols/*pharmacology
;
Peroxisome Proliferator-Activated Receptors/drug effects/physiology
;
NF-kappa B/metabolism
;
Lipoxygenase Inhibitors/pharmacology
;
Humans
;
Flavonoids/*pharmacology
;
Cytokines/biosynthesis
;
Cyclooxygenase Inhibitors/pharmacology
;
Arachidonic Acid/metabolism
;
Anti-Inflammatory Agents/*pharmacology
;
Animals